Medical record-based ascertainment of behaviors suggestive of opioid misuse, diversion, abuse, and/or addiction among individuals showing evidence of doctor/pharmacy shopping

Objectives Doctor/pharmacy shopping, the practice of seeking prescriptions from multiple healthcare sources without their coordination, may be a measure of prescription medicine abuse. This cross-sectional study examined the relationship between a claims-based doctor/pharmacy shopping definition and medical record documented behaviors suggestive of misuse, diversion, abuse and/or addiction. Methods Patients with ≥2 opioid dispensings starting in 2012 in a US administrative claims database were grouped into doctor/pharmacy shopping categories by number of providers and pharmacies used over 18 months: no shopping, minimal shopping, moderate shopping and severe shopping. Medical charts of opioid prescribers were reviewed to identify behaviors suggestive of misuse, diversion, abuse and/or addiction. Results Among 581,940 opioid users, 78% were classified as no shopping, 11% minimal shopping, 8% moderate shopping and 3% severe shopping. Almost 40% of severe shopping patients had no medical record documented behaviors (positive predictive value: 24.3%). Compared with no shopping, the odds ratio [OR] of ≥3 behaviors was 1.70 (95% confidence interval [CI] 0.50–5.78) for minimal shopping, 1.81 (95% CI 0.54–6.03) for moderate shopping, and 8.93 (95% CI 3.12–25.54) for severe shopping. Conclusions Claims-identified severe doctor/pharmacy shopping was strongly associated with behaviors suggestive of misuse, diversion, abuse and/or addiction, but the proportion of medical records documenting these was low.

[1]  M. S. Cepeda,et al.  Possible Opioid Shopping and its Correlates , 2017, The Clinical journal of pain.

[2]  Raeford E. Brown,et al.  The US Opioid Crisis: Current Federal and State Legal Issues , 2017, Anesthesia and analgesia.

[3]  Harold Alan Pincus,et al.  Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians. , 2016, Health affairs.

[4]  Roger Chou,et al.  CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. , 2016, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[5]  R. Chou,et al.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. , 2016, JAMA.

[6]  S. Weiner,et al.  Mandatory use of prescription drug monitoring programs. , 2015, JAMA.

[7]  D. Fife,et al.  Comparison of the Risks of Shopping Behavior and Opioid Abuse Between Tapentadol and Oxycodone and Association of Shopping Behavior and Opioid Abuse , 2014, The Clinical journal of pain.

[8]  D. Fife,et al.  Distance traveled and frequency of interstate opioid dispensing in opioid shoppers and nonshoppers. , 2013, The journal of pain : official journal of the American Pain Society.

[9]  C. O'brien,et al.  Aberrant behaviors in a primary care-based cohort of patients with chronic pain identified as misusing prescription opioids. , 2013, Journal of opioid management.

[10]  J. Farrar,et al.  Usefulness of the opioid risk tool to predict aberrant drug-related behavior in patients receiving opioids for the treatment of chronic pain. , 2013, Journal of opioid management.

[11]  M Soledad Cepeda,et al.  Opioid Shopping Behavior: How Often, How Soon, Which Drugs, and What Payment Method , 2013, Journal of clinical pharmacology.

[12]  Michael J Smith,et al.  Doctor and Pharmacy Shopping for Controlled Substances , 2012, Medical care.

[13]  L. Chibnik,et al.  Craving of prescription opioids in patients with chronic pain: a longitudinal outcomes trial. , 2012, The journal of pain : official journal of the American Pain Society.

[14]  M. Cheatle,et al.  Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors. , 2011, Pain physician.

[15]  H. Cabral,et al.  Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain. , 2010, The journal of pain : official journal of the American Pain Society.

[16]  B. Martin,et al.  Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study , 2010, PAIN.

[17]  S. Butler,et al.  Gender differences in risk factors for aberrant prescription opioid use. , 2010, The journal of pain : official journal of the American Pain Society.

[18]  Meelee Kim,et al.  Usefulness of prescription monitoring programs for surveillance—analysis of Schedule II opioid prescription data in Massachusetts, 1996–2006 , 2010, Pharmacoepidemiology and drug safety.

[19]  S. Butler,et al.  Does Report of Craving Opioid Medication Predict Aberrant Drug Behavior Among Chronic Pain Patients? , 2009, The Clinical journal of pain.

[20]  Robert J. Gatchel,et al.  Predicting Opioid Misuse by Chronic Pain Patients: A Systematic Review and Literature Synthesis , 2008, The Clinical journal of pain.

[21]  J. Potter,et al.  Chronic Pain Severity in Opioid-Dependent Patients , 2008, The American journal of drug and alcohol abuse.

[22]  Marlon P Mundt,et al.  Substance use disorders in a primary care sample receiving daily opioid therapy. , 2007, The journal of pain : official journal of the American Pain Society.

[23]  S. Butler,et al.  Development and validation of the Current Opioid Misuse Measure , 2007, PAIN.

[24]  M. Paasche-Orlow,et al.  Persistent pain is associated with substance use after detoxification: a prospective cohort analysis. , 2007, Addiction.

[25]  Bridget A. Martell,et al.  Systematic Review: Opioid Treatment for Chronic Back Pain: Prevalence, Efficacy, and Association with Addiction , 2007, Annals of Internal Medicine.

[26]  L. Webster,et al.  Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. , 2005, Pain medicine.

[27]  R. Jamison,et al.  Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. , 2004, Journal of pain and symptom management.

[28]  S. Passik,et al.  The need to identify predictors of aberrant drug-related behavior and addiction in patients being treated with opioids for pain. , 2003, Pain medicine.

[29]  K. Miotto,et al.  Screening for addiction in patients with chronic pain and "problematic" substance use: evaluation of a pilot assessment tool. , 1998, Journal of pain and symptom management.

[30]  M. Erjavec,et al.  Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors. , 1997, The Clinical journal of pain.

[31]  Wing Chow,et al.  A Large Cohort Study from a Medication Dispensing Database in the US , 2012 .